Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

1.

Levofloxacin-related seizure activity in a patient with Alzheimer's disease: assessment of potential risk factors.

Bird SB, Orr PG, Mazzola JL, Brush DE, Boyer EW.

J Clin Psychopharmacol. 2005 Jun;25(3):287-8. No abstract available.

PMID:
15876916
[PubMed - indexed for MEDLINE]
2.

Seizures associated with fluoroquinolones.

Kushner JM, Peckman HJ, Snyder CR.

Ann Pharmacother. 2001 Oct;35(10):1194-8. Review.

PMID:
11675843
[PubMed - indexed for MEDLINE]
3.

Seizures associated with levofloxacin: case presentation and literature review.

Bellon A, Perez-Garcia G, Coverdale JH, Chacko RC.

Eur J Clin Pharmacol. 2009 Oct;65(10):959-62. doi: 10.1007/s00228-009-0717-5. Epub 2009 Aug 26. Review.

PMID:
19707748
[PubMed - indexed for MEDLINE]
4.

Seizures in an Alzheimer's disease patient as a complication of colonoscopy premedication with meperidine.

Nagler J, Hammarth PM, Poppers DM.

Dig Dis Sci. 2008 Jan;53(1):62-4. Epub 2007 May 10.

PMID:
17492380
[PubMed - indexed for MEDLINE]
5.

Reduced cholinergic status in hippocampus produces spatial memory deficits when combined with kainic acid induced seizures.

Craig LA, Hong NS, Kopp J, McDonald RJ.

Hippocampus. 2008;18(11):1112-21. doi: 10.1002/hipo.20471.

PMID:
18651618
[PubMed - indexed for MEDLINE]
6.

Epileptic seizures in clinically diagnosed Alzheimer's disease: report from a geriatric medicine population.

Hommet C, Hureaux R, Barré J, Constans T, Berrut G.

Aging Clin Exp Res. 2007 Oct;19(5):430-1.

PMID:
18007124
[PubMed - indexed for MEDLINE]
7.

Seizures associated with ofloxacin therapy.

Traeger SM, Bonfiglio MF, Wilson JA, Martin BR, Nackes NA.

Clin Infect Dis. 1995 Dec;21(6):1504-6. Review.

PMID:
8749646
[PubMed - indexed for MEDLINE]
8.

S-adenosyl methionine: a natural therapeutic agent effective against multiple hallmarks and risk factors associated with Alzheimer's disease.

Shea TB, Chan A.

J Alzheimers Dis. 2008 Feb;13(1):67-70. Review.

PMID:
18334758
[PubMed - indexed for MEDLINE]
9.

Levofloxacin-induced seizures in a patient without predisposing risk factors: the impact of pharmacogenetics.

Gervasoni C, Cattaneo D, Falvella FS, Vitiello P, Cheli S, Milazzo L, Clementi E, Riva A.

Eur J Clin Pharmacol. 2013 Aug;69(8):1611-3. doi: 10.1007/s00228-013-1515-7. Epub 2013 Apr 25. No abstract available.

PMID:
23616064
[PubMed - indexed for MEDLINE]
10.
11.

Androgens and Alzheimer's disease.

Drummond ES, Harvey AR, Martins RN.

Curr Opin Endocrinol Diabetes Obes. 2009 Jun;16(3):254-9. doi: 10.1097/MED.0b013e32832b101f. Review.

PMID:
19373081
[PubMed - indexed for MEDLINE]
12.

Incidence and predictors of seizures in patients with Alzheimer's disease.

Amatniek JC, Hauser WA, DelCastillo-Castaneda C, Jacobs DM, Marder K, Bell K, Albert M, Brandt J, Stern Y.

Epilepsia. 2006 May;47(5):867-72.

PMID:
16686651
[PubMed - indexed for MEDLINE]
13.

Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study.

Belcastro V, Costa C, Galletti F, Pisani F, Calabresi P, Parnetti L.

Eur J Neurol. 2007 Oct;14(10):1176-8.

PMID:
17880574
[PubMed - indexed for MEDLINE]
14.

Hippocampal atrophy may be a predictor of seizures in Alzheimer's disease.

Dhikav V, Anand K.

Med Hypotheses. 2007;69(1):234-5. Epub 2007 Feb 5. No abstract available.

PMID:
17276608
[PubMed - indexed for MEDLINE]
15.

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A.

Brain. 2006 Nov;129(Pt 11):2856-66. Epub 2006 Jul 19.

PMID:
16854944
[PubMed - indexed for MEDLINE]
Free Article
16.

Alterations in excitotoxicity and prostaglandin metabolism in a transgenic mouse model of Alzheimer's disease.

Schulte EC, Slawik H, Schüle R, Gunther T, Hüll M.

Neurochem Int. 2009 Dec;55(7):689-96. doi: 10.1016/j.neuint.2009.06.010. Epub 2009 Jun 26.

PMID:
19560505
[PubMed - indexed for MEDLINE]
17.

Fatty acids, lipid metabolism and Alzheimer pathology.

Hooijmans CR, Kiliaan AJ.

Eur J Pharmacol. 2008 May 6;585(1):176-96. doi: 10.1016/j.ejphar.2007.11.081. Epub 2008 Feb 29. Review.

PMID:
18378224
[PubMed - indexed for MEDLINE]
18.

Outcome of Alzheimer's disease: potential impact of cholinesterase inhibitors.

Gillette-Guyonnet S, Andrieu S, Cortes F, Nourhashemi F, Cantet C, Ousset PJ, Reynish E, Grandjean H, Vellas B.

J Gerontol A Biol Sci Med Sci. 2006 May;61(5):516-20.

PMID:
16720751
[PubMed - indexed for MEDLINE]
19.

The renin-angiotensin system, hypertension and cognitive dysfunction in Alzheimer's disease: new therapeutic potential.

Takeda S, Sato N, Ogihara T, Morishita R.

Front Biosci. 2008 Jan 1;13:2253-65. Review.

PMID:
17981707
[PubMed - indexed for MEDLINE]
20.

Influence of galantamine on vasomotor reactivity in Alzheimer's disease and vascular dementia due to cerebral microangiopathy.

Bär KJ, Boettger MK, Seidler N, Mentzel HJ, Terborg C, Sauer H.

Stroke. 2007 Dec;38(12):3186-92. Epub 2007 Oct 25.

PMID:
17962592
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk